Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group.
about
Enhancing Adolescent and Young Adult Oncology Research Within the National Clinical Trials Network: Rationale, Progress, and Emerging StrategiesEffect of age and body weight on toxicity and survival in pediatric acute myeloid leukemia: results from NOPHO-AML 2004.Survival Impact of Early Post-Transplant Toxicities in Pediatric and Adolescent Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Malignant and Nonmalignant Diseases: Recognizing Risks and Optimizing OutcomesInclusion of Adolescents and Young Adults in Cancer Clinical Trials.Enhanced generation of cord blood hematopoietic stem and progenitor cells by culture with StemRegenin1 and Delta1(Ext-IgG.).The Initiative to Maximize Progress in Adolescent and Young Adult Cancer Therapy (IMPACT) Cohort Study: a population-based cohort of young Canadians with cancer.Medication adherence decision-making among adolescents and young adults with cancerPatient Characteristics and Outcomes in Adolescents and Young Adults (AYA) With Acute Myeloid Leukemia (AML).Rhodium(II) Proximity-Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti-Leukemia Activity.Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials.A critical review of which children with acute myeloid leukaemia need stem cell procedures.Association between body mass index at diagnosis and pediatric leukemia mortality and relapse: a systematic review and meta-analysis.Evaluation of treatment-related mortality among paediatric cancer deaths: a population based analysis.Comparison of survival of adolescents and young adults with hematologic malignancies in Osaka, Japan.Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols.A prospective, observational cohort study comparing cancer clinical trial availability and enrollment between early adolescents/young adults and children.Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: Impact of Care at Specialized Cancer Centers on Survival Outcome.Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia.Treatment-related mortality in newly diagnosed pediatric cancer: a population-based analysis.Acute myelogenous leukemia in adolescents and young adults.Sex disparity in childhood and young adult acute myeloid leukemia (AML) survival: Evidence from US population data.
P2860
Q28086955-B527A801-9F26-494E-8C6D-E15214E4BCA0Q33573539-5068C296-4747-4AB5-BE58-F5222726EA19Q33870341-88C04DB2-F5E0-48B0-BBA0-4C9C0913218AQ33922505-2725C691-C8FB-4114-B572-77AFAE17038FQ34315848-D1A92DA7-A676-44AC-A4C3-703C9383F204Q34491288-068F138E-94A9-4641-A794-76232D87BD8EQ36446637-EF81D637-468A-4F0B-B4C6-AC349A588AC4Q36739522-C5408CDF-7B37-4FDD-B9E6-1708E7B69159Q37295115-005D505A-9DAD-47AF-977E-AED60A3E92FEQ37324869-215531F6-C01F-4694-B167-EDDAD61A774CQ38205864-7600E65F-AE40-48D3-A19D-C80A91DEDCC7Q38603452-F3322B4F-BB89-449B-84C9-46E7EF967E0DQ38769534-DBCA4568-3D8A-4500-B285-9B1272A0D6FDQ40179856-42379709-631F-4013-9874-BB773DD1EF6AQ40781300-83894804-C8FD-461C-A06D-E31B2B274AA3Q45939546-6CED552A-0816-4646-9EAF-87CCB1A9C73FQ46143417-8547AD98-1800-4DD3-A23F-CF606A2CD9D8Q47805959-DF2F8767-3AC1-413F-954F-D0F96A20B8F4Q50422207-CAA76661-F270-4219-A987-52058FF2F86CQ52318200-6F91B543-94AB-4BCC-9BAF-D63A367D1719Q55163802-6CE72CE2-2E6E-4A36-B272-0CF0098818E5
P2860
Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Differences in outcomes of new ...... the Children's Oncology Group.
@ast
Differences in outcomes of new ...... the Children's Oncology Group.
@en
type
label
Differences in outcomes of new ...... the Children's Oncology Group.
@ast
Differences in outcomes of new ...... the Children's Oncology Group.
@en
prefLabel
Differences in outcomes of new ...... the Children's Oncology Group.
@ast
Differences in outcomes of new ...... the Children's Oncology Group.
@en
P2093
P2860
P356
P1433
P1476
Differences in outcomes of new ...... the Children's Oncology Group.
@en
P2093
Alan Gamis
Beverly J Lange
David R Freyer
Janet Franklin
Jason Canner
John Horan
John Perentesis
Robert B Gerbing
Soheil Meshinchi
Todd A Alonzo
P2860
P304
P356
10.1002/CNCR.28342
P407
P577
2013-09-19T00:00:00Z